Shares of Carl Zeiss Meditec AG (OTCMKTS:CZMWY) have been given a consensus rating of “Hold” by the six research firms that are currently covering the company, MarketBeat.com reports. Five research analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company.
Several research analysts have commented on CZMWY shares. DZ Bank raised shares of Carl Zeiss Meditec from a “sell” rating to a “hold” rating in a research note on Friday, January 22nd. Kepler Capital Markets raised shares of Carl Zeiss Meditec from a “reduce” rating to a “hold” rating in a research note on Friday, April 16th. Berenberg Bank reaffirmed a “hold” rating on shares of Carl Zeiss Meditec in a research note on Wednesday, January 20th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Carl Zeiss Meditec in a research note on Tuesday, April 20th. Finally, Commerzbank raised shares of Carl Zeiss Meditec from a “reduce” rating to a “hold” rating in a research note on Tuesday, February 16th.
Shares of CZMWY stock traded down $2.76 during trading hours on Tuesday, hitting $168.39. 386 shares of the company’s stock were exchanged, compared to its average volume of 655. Carl Zeiss Meditec has a 12-month low of $90.65 and a 12-month high of $177.28. The business’s 50 day simple moving average is $167.72 and its 200-day simple moving average is $150.14.
Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, France, Spain, India, the United Kingdom, Turkey, North Africa, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.
Recommended Story: Are FAANG stocks a good investment?
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.